Whole-body glycolysis measured by the deuterated-glucose disposal test correlates highly with insulin resistance in vivo
- PMID: 17259480
- DOI: 10.2337/dc06-1809
Whole-body glycolysis measured by the deuterated-glucose disposal test correlates highly with insulin resistance in vivo
Abstract
Objective: The purpose of this study was to compare an in vivo test of whole-body glycolysis, the deuterated-glucose disposal test (2H-GDT), with insulin sensitivity measured by the euglycemic-hyperinsulinemic glucose clamp and the steady-state plasma glucose (SSPG) test.
Research design and methods: The 2H-GDT consists of an oral glucose challenge containing deuterated glucose, followed by measurement of heavy water (2H2O) production, which represents whole-body glycolytic disposal of the glucose load. 2H2O production is corrected for ambient insulin concentration as an index of tissue insulin sensitivity. The 2H-GDT was compared with euglycemic-hyperinsulinemic glucose clamps in healthy lean subjects (n = 8) and subjects with the metabolic syndrome (n = 9) and with the SSPG test in overweight (n = 12) and obese (n = 6) subjects.
Results: A strong correlation with the clamp was observed for the 75-g and 30-g 2H-GDT (r = 0.95, P < 0.0001 and r = 0.88, P < 0.0001, respectively). The 2H-GDT and clamp studies revealed marked insulin resistance in subjects with metabolic syndrome compared with lean control subjects. The correlation with the clamp was maintained in each group (lean, r = 0.86, P < 0.01; metabolic syndrome, r = 0.81, P < 0.01) for the 75-g test. The 2H-GDT also correlated strongly with the SSPG test (r = -0.87, P < 0.0001) in overweight and obese subjects.
Conclusions: The 2H-GDT, which measures whole-body glycolysis in humans in a quantitative manner, correlates highly with the euglycemic-hyperinsulinemic glucose clamp and the SSPG test. Impaired insulin-mediated whole-body glycolysis is a feature of insulin resistance, which provides a means of assessing insulin sensitivity in vivo.
Similar articles
-
The Clamp-Like Index: a novel and highly sensitive insulin sensitivity index to calculate hyperinsulinemic clamp glucose infusion rates from oral glucose tolerance tests in nondiabetic subjects.Diabetes Care. 2007 Sep;30(9):2374-80. doi: 10.2337/dc07-0422. Epub 2007 Jun 26. Diabetes Care. 2007. PMID: 17595351
-
The effect of 6 months supplementation with conjugated linoleic acid on insulin resistance in overweight and obese.Int J Obes (Lond). 2007 Jul;31(7):1148-54. doi: 10.1038/sj.ijo.0803482. Epub 2006 Oct 10. Int J Obes (Lond). 2007. PMID: 17031391 Clinical Trial.
-
Measurement of insulin sensitivity in children: comparison between the euglycemic-hyperinsulinemic clamp and surrogate measures.Diabetes Care. 2008 Apr;31(4):783-8. doi: 10.2337/dc07-1376. Epub 2008 Jan 3. Diabetes Care. 2008. PMID: 18174496
-
Measures of insulin sensitivity.Clin Lab Med. 2006 Sep;26(3):611-33, vi. doi: 10.1016/j.cll.2006.06.007. Clin Lab Med. 2006. PMID: 16938587 Review.
-
The role of the transcapillary insulin transport in the efficiency of insulin action: studies with glucose clamps and the minimal model.Horm Metab Res Suppl. 1990;24:49-56. Horm Metab Res Suppl. 1990. PMID: 2272626 Review.
Cited by
-
SIRT5 Regulates both Cytosolic and Mitochondrial Protein Malonylation with Glycolysis as a Major Target.Mol Cell. 2015 Jul 16;59(2):321-32. doi: 10.1016/j.molcel.2015.05.022. Epub 2015 Jun 11. Mol Cell. 2015. PMID: 26073543 Free PMC article.
-
Metabolic Inflexibility Is an Early Marker of Bed-Rest-Induced Glucose Intolerance Even When Fat Mass Is Stable.J Clin Endocrinol Metab. 2018 May 1;103(5):1910-1920. doi: 10.1210/jc.2017-02267. J Clin Endocrinol Metab. 2018. PMID: 29546280 Free PMC article. Clinical Trial.
-
Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans.J Clin Invest. 2009 May;119(5):1322-34. doi: 10.1172/JCI37385. Epub 2009 Apr 20. J Clin Invest. 2009. PMID: 19381015 Free PMC article.
-
Metabolic responses to prolonged consumption of glucose- and fructose-sweetened beverages are not associated with postprandial or 24-h glucose and insulin excursions.Am J Clin Nutr. 2011 Jul;94(1):112-9. doi: 10.3945/ajcn.110.002246. Epub 2011 May 25. Am J Clin Nutr. 2011. PMID: 21613559 Free PMC article. Clinical Trial.
-
Fructose consumption: recent results and their potential implications.Ann N Y Acad Sci. 2010 Mar;1190:15-24. doi: 10.1111/j.1749-6632.2009.05266.x. Ann N Y Acad Sci. 2010. PMID: 20388133 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical